FI972433A0 - Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia - Google Patents

Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia

Info

Publication number
FI972433A0
FI972433A0 FI972433A FI972433A FI972433A0 FI 972433 A0 FI972433 A0 FI 972433A0 FI 972433 A FI972433 A FI 972433A FI 972433 A FI972433 A FI 972433A FI 972433 A0 FI972433 A0 FI 972433A0
Authority
FI
Finland
Prior art keywords
inflammation
fragments
treatment
compositions containing
rantes peptide
Prior art date
Application number
FI972433A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972433L (fi
FI972433A7 (fi
Inventor
Timothy Nigel Carl Wells
Amanda Elizabeth Inn Proudfoot
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9424835.8A external-priority patent/GB9424835D0/en
Priority claimed from GBGB9512319.6A external-priority patent/GB9512319D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI972433L publication Critical patent/FI972433L/fi
Publication of FI972433A7 publication Critical patent/FI972433A7/fi
Publication of FI972433A0 publication Critical patent/FI972433A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI972433A 1994-12-08 1995-12-07 Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia FI972433A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9424835.8A GB9424835D0 (en) 1994-12-08 1994-12-08 Substances and their uses
GBGB9512319.6A GB9512319D0 (en) 1995-06-16 1995-06-16 Substances and their uses
PCT/GB1995/002861 WO1996017935A2 (en) 1994-12-08 1995-12-07 Rantes peptide and fragments and compositions comprising it for treatment of inflammation

Publications (3)

Publication Number Publication Date
FI972433L FI972433L (fi) 1997-06-06
FI972433A7 FI972433A7 (fi) 1997-06-06
FI972433A0 true FI972433A0 (fi) 1997-06-06

Family

ID=26306133

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972433A FI972433A0 (fi) 1994-12-08 1995-12-07 Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia

Country Status (15)

Country Link
US (2) US6159711A (pl)
EP (1) EP0796330A1 (pl)
JP (1) JPH10510151A (pl)
CN (1) CN1087346C (pl)
AU (1) AU688641B2 (pl)
BR (1) BR9509890A (pl)
CA (1) CA2207036A1 (pl)
CZ (1) CZ290850B6 (pl)
FI (1) FI972433A0 (pl)
HU (1) HU221089B1 (pl)
MX (1) MX9703889A (pl)
NO (1) NO972620L (pl)
NZ (1) NZ296570A (pl)
PL (1) PL182786B1 (pl)
WO (1) WO1996017935A2 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510151A (ja) * 1994-12-08 1998-10-06 グラクソ、グループ、リミテッド Ｒａｎｔｅｓペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
AU4561497A (en) * 1996-09-25 1998-04-17 British Biotech Pharmaceuticals Limited Human rantes mutants incapable of aggregate formation
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6852508B1 (en) 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
IT1291353B1 (it) * 1997-05-12 1999-01-07 San Raffaele Centro Fond Peptidi con attivita' antivirale
US6168784B1 (en) 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use
EP0906954A1 (en) * 1997-09-29 1999-04-07 Applied Research Systems ARS Holding N.V. Amino-terminal truncated c-c chemokines as chemokine antagonist
MXPA00003885A (es) * 1997-10-22 2004-04-23 Inst Genetics Llc Quimiocinas con modificiaciones de la terminacion amino.
DE69832197T2 (de) * 1997-12-23 2006-05-24 Fondazione Centro San Raffaele Del Monte Tabor Rantes-mutanten und therapeutische anwendungen davon
US6121023A (en) * 1998-01-22 2000-09-19 Akzo Nobel N.V. Isothermal transcription based assay for the detection and quantification of the chemokine rantes
EP1000626A1 (en) 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Chemokine receptor antagonist and cyclosporin in combined therapy
IT1303736B1 (it) * 1998-11-11 2001-02-23 San Raffaele Centro Fond Peptidi derivati da rantes con attivita' anti-hiv.
WO2000056879A1 (en) * 1999-03-22 2000-09-28 Universität Zürich TRANSFORMING GROWTH FACTOR (TFG) β SUPERFAMILY ANTAGONISTS
WO2002020033A1 (en) 2000-09-08 2002-03-14 Gryphon Therapeutics, Inc. Polymer-modified synthetic proteins
US7998681B2 (en) * 2000-10-06 2011-08-16 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Diagnosis and therapy of antibody-mediated inflammatory auto-immune disorders
US8153121B2 (en) * 2000-10-06 2012-04-10 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
EP1506400A2 (en) * 2001-10-30 2005-02-16 President And Fellows Of Harvard College Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
AU2002358144B2 (en) * 2001-12-17 2008-10-02 Laboratoires Serono Sa Chemokine mutants acting as chemokine antagonists
US20040191215A1 (en) * 2003-03-25 2004-09-30 Michael Froix Compositions for induction of a therapeutic response
US7390788B2 (en) * 2005-06-23 2008-06-24 Pert Candace B Peptide pharmaceutical compositions
WO2008015199A1 (en) * 2006-07-31 2008-02-07 Laboratoires Serono S.A. Chemokine antagonists
MX2010001307A (es) 2007-08-02 2010-07-30 Novimmune Sa Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos.
US9034313B2 (en) 2010-02-08 2015-05-19 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
WO2013024022A1 (en) 2011-08-12 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US20240409596A1 (en) 2021-10-06 2024-12-12 Virothera Limited Novel immune regulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510151A (ja) * 1994-12-08 1998-10-06 グラクソ、グループ、リミテッド Ｒａｎｔｅｓペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物

Also Published As

Publication number Publication date
MX9703889A (es) 1997-08-30
NO972620L (no) 1997-08-06
NO972620D0 (no) 1997-06-06
JPH10510151A (ja) 1998-10-06
FI972433L (fi) 1997-06-06
AU4120896A (en) 1996-06-26
PL320565A1 (en) 1997-10-13
FI972433A7 (fi) 1997-06-06
CZ290850B6 (cs) 2002-10-16
BR9509890A (pt) 1997-12-30
CN1087346C (zh) 2002-07-10
CN1168697A (zh) 1997-12-24
PL182786B1 (pl) 2002-02-28
US6159711A (en) 2000-12-12
AU688641B2 (en) 1998-03-12
US6555105B1 (en) 2003-04-29
EP0796330A1 (en) 1997-09-24
WO1996017935A3 (en) 1996-08-22
HU221089B1 (en) 2002-08-28
CZ171997A3 (en) 1997-11-12
NZ296570A (en) 1998-11-25
HUT77075A (hu) 1998-03-02
CA2207036A1 (en) 1996-06-13
WO1996017935A2 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
FI972433A0 (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
FI970920L (fi) Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon
FI963252L (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
BR9604959A (pt) Composição e método para o tratamento de desensibilização de dentes
LV11865A (lv) Kompozicijas un panemieni tuklo sunu iekaisumu arstesanai
BR9504998A (pt) Composições cosméticas de uso tópico utilização de composições processo de tratamento cosmético e utilização de uma mistura
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
IL125446A0 (en) Pharmaceutical composition for the treatment of asthma allergy and inflammation
EP0727990A4 (en) CONNECTIONS, PREPARATIONS AND TREATMENT OF ALLERGIES AND IGNITIONS
EP0722322A4 (en) CONNECTIONS AND COMPOSITIONS FOR THE TREATMENT OF ALLERGIES AND IGNITIONS
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
FI971427L (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
NO952568D0 (no) Behandling av cellulosemateriale og blandinger for anvendelse for dette
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
NO982562D0 (no) Sammensetning for behandling av smerte
FI944687A7 (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi
FI954213L (fi) Kasvainten vastaisia koostumuksia ja hoitomenetelmiä

Legal Events

Date Code Title Description
MA Patent expired